BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19569232)

  • 1. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
    Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
    Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
    Ye CC; Wang J
    J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.
    Li W; Xiao D; Wu H; Xu L
    Clin Exp Med; 2020 Feb; 20(1):73-78. PubMed ID: 31625007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.
    Grünhage F; Jungck M; Lamberti C; Berg C; Becker U; Schulte-Witte H; Plassmann D; Rahner N; Aretz S; Friedrichs N; Buettner R; Sauerbruch T; Lammert F
    Int J Colorectal Dis; 2008 Feb; 23(2):147-54. PubMed ID: 17960397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.
    Sun N; Chen J; Hu G; Chen X; Jiang J; Zhang L; Wu H
    Crit Rev Eukaryot Gene Expr; 2017; 27(4):347-354. PubMed ID: 29283329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
    Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
    J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
    Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
    Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
    Wang Q; Gu D; Wang M; Zhang Z; Tang J; Chen J
    DNA Cell Biol; 2011 Jun; 30(6):395-400. PubMed ID: 21214416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
    Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
    Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
    Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
    Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility genetic variants associated with early-onset colorectal cancer.
    Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
    Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
    Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
    World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E-cadherin (CDH1) -C160A polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Geng P; Chen Y; Ou J; Yin X; Sa R; Liang H
    DNA Cell Biol; 2012 Jun; 31(6):1070-7. PubMed ID: 22339265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDH1 promoter polymorphism (-347G-->GA) is a possible prognostic factor in sporadic colorectal cancer.
    Zou XP; Dai WJ; Cao J
    World J Gastroenterol; 2009 Nov; 15(42):5340-5. PubMed ID: 19908344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
    Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
    Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer.
    Pittman AM; Webb E; Carvajal-Carmona L; Howarth K; Di Bernardo MC; Broderick P; Spain S; Walther A; Price A; Sullivan K; Twiss P; Fielding S; Rowan A; Jaeger E; Vijayakrishnan J; Chandler I; Penegar S; Qureshi M; Lubbe S; Domingo E; Kemp Z; Barclay E; Wood W; Martin L; Gorman M; Thomas H; Peto J; Bishop T; Gray R; Maher ER; Lucassen A; Kerr D; Evans GR; ; van Wezel T; Morreau H; Wijnen JT; Hopper JL; Southey MC; Giles GG; Severi G; Castellví-Bel S; Ruiz-Ponte C; Carracedo A; Castells A; ; Försti A; Hemminki K; Vodicka P; Naccarati A; Lipton L; Ho JW; Cheng KK; Sham PC; Luk J; Agúndez JA; Ladero JM; de la Hoya M; Caldés T; Niittymäki I; Tuupanen S; Karhu A; Aaltonen LA; Cazier JB; Tomlinson IP; Houlston RS
    Hum Mol Genet; 2008 Dec; 17(23):3720-7. PubMed ID: 18753146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
    Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
    Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.